speb/financial-data huggingface dataset:
CHY balance_sheet (annual, 2023-10-31) — Total Equity Gross Minority Interest: 724820768.00
CHY balance_sheet (annual, 2023-10-31) — Total Liabilities Net Minority Interest: 490024530.00
CHY balance_sheet (annual, 2023-10-31) — Treasury Shares Number: 0.00
CHY income_statement (annual, 2024-10-31) — +Operating Expense: 720767.00
CHY income_statement (annual, 2024-10-31) — +Total Revenue: 179451965.00
CHY balance_sheet (annual, 2024-10-31) — Accounts Payable: 7366833.00
CHY balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 7366833.00
CHY income_statement (annual, 2024-10-31) — Basic Average Shares: 76380854.00
CHY income_statement (annual, 2024-10-31) — Basic EPS: 2.34
CHY cash_flow (annual, 2024-10-31) — Beginning Cash Position: 16876329.00
CHY balance_sheet (annual, 2024-10-31) — Capital Stock: 871169523.00
CHY balance_sheet (quarterly, 2024-10-31) — Capital Stock: 871169523.00
CHY balance_sheet (annual, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 27753599.00
CHY balance_sheet (quarterly, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 27753599.00
CHY cash_flow (annual, 2024-10-31) — Cash Dividends Paid: -83987641.00
CHY cash_flow (annual, 2024-10-31) — Change In Other Current Assets: -51585.00
CHY cash_flow (annual, 2024-10-31) — Change In Other Current Liabilities: 0.00
CHY cash_flow (annual, 2024-10-31) — Change In Payable: 168011.00
CHY cash_flow (annual, 2024-10-31) — Change In Prepaid Assets: -74730.00
CHY cash_flow (annual, 2024-10-31) — Change In Receivables: -121530.00
CHY cash_flow (annual, 2024-10-31) — Change In Working Capital: -79834.00
CHY cash_flow (annual, 2024-10-31) — Changes In Cash: 10877270.00
CHY balance_sheet (annual, 2024-10-31) — Common Stock: 871169523.00
CHY balance_sheet (quarterly, 2024-10-31) — Common Stock: 871169523.00
CHY cash_flow (annual, 2024-10-31) — Common Stock Dividend Paid: -83987641.00
CHY balance_sheet (annual, 2024-10-31) — Common Stock Equity: 819582208.00
CHY balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 819582208.00
CHY balance_sheet (annual, 2024-10-31) — Derivative Product Liabilities: 0.00
CHY balance_sheet (quarterly, 2024-10-31) — Derivative Product Liabilities: 0.00
CHY income_statement (annual, 2024-10-31) — Diluted Average Shares: 76380854.00
CHY income_statement (annual, 2024-10-31) — Diluted EPS: 2.34
CHY income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: 178731198.00
CHY cash_flow (annual, 2024-10-31) — End Cash Position: 27753599.00
CHY balance_sheet (annual, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1273710762.00
CHY balance_sheet (quarterly, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1273710762.00
CHY cash_flow (annual, 2024-10-31) — Financing Cash Flow: -84294541.00
CHY cash_flow (annual, 2024-10-31) — Free Cash Flow: 95171811.00
CHY cash_flow (annual, 2024-10-31) — Gain Loss On Investment Securities: -103934641.00
CHY income_statement (annual, 2024-10-31) — Gain On Sale Of Security: 63881724.00
CHY income_statement (annual, 2024-10-31) — General And Administrative Expense: 600712.00
CHY income_statement (annual, 2024-10-31) — Interest Expense: 25434997.00
CHY income_statement (annual, 2024-10-31) — Interest Income: 37806249.00
CHY balance_sheet (annual, 2024-10-31) — Invested Capital: 1160482208.00
CHY balance_sheet (quarterly, 2024-10-31) — Invested Capital: 1160482208.00
CHY balance_sheet (annual, 2024-10-31) — Investmentin Financial Assets: 1274581172.00
CHY balance_sheet (quarterly, 2024-10-31) — Investmentin Financial Assets: 1274581172.00
CHY balance_sheet (annual, 2024-10-31) — Investments And Advances: 1274581172.00
CHY balance_sheet (quarterly, 2024-10-31) — Investments And Advances: 1274581172.00
CHY cash_flow (annual, 2024-10-31) — Issuance Of Debt: 36500000.00
CHY balance_sheet (annual, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 340900000.00
CHY balance_sheet (quarterly, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 340900000.00
CHY cash_flow (annual, 2024-10-31) — Long Term Debt Issuance: 36500000.00
CHY cash_flow (annual, 2024-10-31) — Long Term Debt Payments: -36000000.00
CHY balance_sheet (annual, 2024-10-31) — Net Debt: 340900000.00
CHY balance_sheet (quarterly, 2024-10-31) — Net Debt: 340900000.00
CHY income_statement (annual, 2024-10-31) — Net Income: 178731198.00
CHY income_statement (annual, 2024-10-31) — Net Income Common Stockholders: 178731198.00
CHY income_statement (annual, 2024-10-31) — Net Income Continuous Operations: 178731198.00
CHY income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: 178731198.00
CHY income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: 178731198.00
CHY cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: 178731198.00
CHY income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: 178731198.00
CHY income_statement (annual, 2024-10-31) — Net Interest Income: 12371252.00
CHY cash_flow (annual, 2024-10-31) — Net Issuance Payments Of Debt: 500000.00
CHY cash_flow (annual, 2024-10-31) — Net Long Term Debt Issuance: 500000.00
CHY cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 0.00
CHY cash_flow (annual, 2024-10-31) — Net Preferred Stock Issuance: -433647.00
CHY balance_sheet (annual, 2024-10-31) — Net Tangible Assets: 819582208.00
CHY balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 819582208.00
CHY income_statement (annual, 2024-10-31) — Normalized Income: 178731198.00
CHY cash_flow (annual, 2024-10-31) — Operating Cash Flow: 95171811.00
CHY income_statement (annual, 2024-10-31) — Operating Revenue: 179451965.00
CHY balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 75582242.00
CHY balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 75582242.00
CHY cash_flow (annual, 2024-10-31) — Other Non Cash Items: 20455088.00
CHY income_statement (annual, 2024-10-31) — Other Operating Expenses: 120055.00
CHY balance_sheet (annual, 2024-10-31) — Other Payable: 2698961.00
CHY balance_sheet (quarterly, 2024-10-31) — Other Payable: 2698961.00
CHY balance_sheet (annual, 2024-10-31) — Payables: 10065794.00
CHY balance_sheet (quarterly, 2024-10-31) — Payables: 10065794.00
CHY balance_sheet (annual, 2024-10-31) — Preferred Securities Outside Stock Equity: 143763808.00
CHY balance_sheet (quarterly, 2024-10-31) — Preferred Securities Outside Stock Equity: 143763808.00
CHY cash_flow (annual, 2024-10-31) — Preferred Stock Payments: -433647.00
CHY balance_sheet (annual, 2024-10-31) — Prepaid Assets: 504272.00
CHY balance_sheet (quarterly, 2024-10-31) — Prepaid Assets: 504272.00
CHY income_statement (annual, 2024-10-31) — Pretax Income: 178731198.00
CHY balance_sheet (annual, 2024-10-31) — Receivables: 11472767.00
CHY balance_sheet (quarterly, 2024-10-31) — Receivables: 11472767.00
CHY cash_flow (annual, 2024-10-31) — Repayment Of Debt: -36000000.00
CHY cash_flow (annual, 2024-10-31) — Repurchase Of Capital Stock: -433647.00
CHY balance_sheet (annual, 2024-10-31) — Retained Earnings: -51587315.00
CHY balance_sheet (quarterly, 2024-10-31) — Retained Earnings: -51587315.00
CHY income_statement (annual, 2024-10-31) — Selling General And Administration: 600712.00
CHY balance_sheet (annual, 2024-10-31) — Share Issued: 75582242.00
CHY balance_sheet (quarterly, 2024-10-31) — Share Issued: 75582242.00
CHY balance_sheet (annual, 2024-10-31) — Stockholders Equity: 819582208.00
CHY balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: 819582208.00
CHY balance_sheet (annual, 2024-10-31) — Tangible Book Value: 819582208.00
CHY balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 819582208.00
CHY income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
CHY income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.21
CHY balance_sheet (annual, 2024-10-31) — Total Assets: 1314506363.00
CHY balance_sheet (quarterly, 2024-10-31) — Total Assets: 1314506363.00
CHY balance_sheet (annual, 2024-10-31) — Total Capitalization: 1160482208.00
CHY balance_sheet (quarterly, 2024-10-31) — Total Capitalization: 1160482208.00
CHY balance_sheet (annual, 2024-10-31) — Total Debt: 340900000.00
CHY balance_sheet (quarterly, 2024-10-31) — Total Debt: 340900000.00
CHY balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 819582208.00
CHY balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 819582208.00
CHY balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 494924155.00
CHY balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 494924155.00
CHY balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 19228531.00
CHY balance_sheet (quarterly, 2025-04-30) — Capital Stock: 893294262.00
CHY balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Federal Funds Sold: 74071637.00
CHY balance_sheet (quarterly, 2025-04-30) — Common Stock: 893294262.00
CHY balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 779401793.00
CHY balance_sheet (quarterly, 2025-04-30) — Derivative Product Liabilities: 0.00
CHY balance_sheet (quarterly, 2025-04-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1174302720.00
CHY balance_sheet (quarterly, 2025-04-30) — Invested Capital: 1093301793.00
CHY balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 1174313230.00
CHY balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 1174313230.00
CHY balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 313900000.00
CHY balance_sheet (quarterly, 2025-04-30) — Net Debt: 313900000.00
CHY balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 779401793.00
CHY balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 79140284.00
CHY balance_sheet (quarterly, 2025-04-30) — Other Payable: 2483399.00
CHY balance_sheet (quarterly, 2025-04-30) — Payables: 21711930.00
CHY balance_sheet (quarterly, 2025-04-30) — Preferred Securities Outside Stock Equity: 143872435.00
CHY balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 522623.00
CHY balance_sheet (quarterly, 2025-04-30) — Receivables: 9978668.00
CHY balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -113892469.00
CHY balance_sheet (quarterly, 2025-04-30) — Share Issued: 79140284.00
CHY balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 779401793.00
CHY balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 779401793.00
CHY balance_sheet (quarterly, 2025-04-30) — Total Assets: 1259076210.00
CHY balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 1093301793.00
CHY balance_sheet (quarterly, 2025-04-30) — Total Debt: 313900000.00
CHY balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 779401793.00
CHY balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 479674417.00
CHY income_statement (annual, 2025-10-31) — +Operating Expense: 696494.00
CHY income_statement (annual, 2025-10-31) — +Total Revenue: 186662512.00
CHY balance_sheet (annual, 2025-10-31) — Accounts Payable: 7328618.00
CHY balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 7328618.00
CHY cash_flow (annual, 2025-10-31) — Beginning Cash Position: 27753599.00
CHY balance_sheet (annual, 2025-10-31) — Capital Stock: 847245779.00
CHY balance_sheet (quarterly, 2025-10-31) — Capital Stock: 847245779.00
CHY balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 35097531.00
CHY balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 35097531.00
CHY cash_flow (annual, 2025-10-31) — Cash Dividends Paid: -87944773.00
CHY cash_flow (annual, 2025-10-31) — Change In Other Current Assets: -37820.00
CHY cash_flow (annual, 2025-10-31) — Change In Other Current Liabilities: 0.00
CHY cash_flow (annual, 2025-10-31) — Change In Payable: -107596.00
CHY cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: -942.00
CHY cash_flow (annual, 2025-10-31) — Change In Receivables: 416296.00
CHY cash_flow (annual, 2025-10-31) — Change In Working Capital: 269938.00
CHY cash_flow (annual, 2025-10-31) — Changes In Cash: 9197180.00
CHY balance_sheet (annual, 2025-10-31) — Common Stock: 847245779.00
CHY balance_sheet (quarterly, 2025-10-31) — Common Stock: 847245779.00
CHY cash_flow (annual, 2025-10-31) — Common Stock Dividend Paid: -87944773.00
CHY balance_sheet (annual, 2025-10-31) — Common Stock Equity: 885187638.00
CHY balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 885187638.00
CHY cash_flow (annual, 2025-10-31) — Common Stock Issuance: 24709998.00
CHY balance_sheet (annual, 2025-10-31) — Derivative Product Liabilities: 0.00
CHY balance_sheet (quarterly, 2025-10-31) — Derivative Product Liabilities: 0.00
CHY income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 185966018.00
CHY cash_flow (annual, 2025-10-31) — End Cash Position: 36950779.00
CHY balance_sheet (annual, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1285379019.00
CHY balance_sheet (quarterly, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1285379019.00
CHY cash_flow (annual, 2025-10-31) — Financing Cash Flow: -75295200.00
CHY cash_flow (annual, 2025-10-31) — Free Cash Flow: 84492380.00
CHY cash_flow (annual, 2025-10-31) — Gain Loss On Investment Securities: -123946991.00
CHY income_statement (annual, 2025-10-31) — Gain On Sale Of Security: 118278674.00
CHY income_statement (annual, 2025-10-31) — General And Administrative Expense: 589575.00
CHY income_statement (annual, 2025-10-31) — Interest Expense: 22416173.00
CHY income_statement (annual, 2025-10-31) — Interest Income: 37874281.00
CHY balance_sheet (annual, 2025-10-31) — Invested Capital: 1186837638.00
CHY balance_sheet (quarterly, 2025-10-31) — Invested Capital: 1186837638.00
CHY balance_sheet (annual, 2025-10-31) — Investmentin Financial Assets: 1285645623.00
CHY balance_sheet (quarterly, 2025-10-31) — Investmentin Financial Assets: 1285645623.00
CHY balance_sheet (annual, 2025-10-31) — Investments And Advances: 1285645623.00
CHY balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 1285645623.00
CHY cash_flow (annual, 2025-10-31) — Issuance Of Capital Stock: 24709998.00
CHY cash_flow (annual, 2025-10-31) — Issuance Of Debt: 15000000.00
CHY balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 301650000.00
CHY balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 301650000.00
CHY cash_flow (annual, 2025-10-31) — Long Term Debt Issuance: 15000000.00
CHY cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -27000000.00
CHY cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: 24709998.00
CHY balance_sheet (annual, 2025-10-31) — Net Debt: 301650000.00
CHY balance_sheet (quarterly, 2025-10-31) — Net Debt: 301650000.00
CHY income_statement (annual, 2025-10-31) — Net Income: 185966018.00
CHY income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 185966018.00
CHY income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 185966018.00
CHY income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 185966018.00
CHY income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 185966018.00
CHY cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 185966018.00
CHY income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 185966018.00
CHY income_statement (annual, 2025-10-31) — Net Interest Income: 15458108.00
CHY cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -12000000.00
CHY cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: -12000000.00
CHY cash_flow (annual, 2025-10-31) — Net Other Financing Charges: 0.00
CHY cash_flow (annual, 2025-10-31) — Net Preferred Stock Issuance: -3.00
CHY balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 885187638.00
CHY balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 885187638.00
CHY income_statement (annual, 2025-10-31) — Normalized Income: 185966018.00
CHY cash_flow (annual, 2025-10-31) — Operating Cash Flow: 84492380.00
CHY income_statement (annual, 2025-10-31) — Operating Revenue: 186662512.00
CHY balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 80025019.00
CHY balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 80025019.00
CHY cash_flow (annual, 2025-10-31) — Other Non Cash Items: 22203415.00
CHY income_statement (annual, 2025-10-31) — Other Operating Expenses: 106919.00
CHY balance_sheet (annual, 2025-10-31) — Other Payable: 2359960.00
CHY balance_sheet (quarterly, 2025-10-31) — Other Payable: 2359960.00
CHY balance_sheet (annual, 2025-10-31) — Payables: 9688578.00
CHY balance_sheet (quarterly, 2025-10-31) — Payables: 9688578.00
CHY balance_sheet (annual, 2025-10-31) — Preferred Securities Outside Stock Equity: 132287284.00
CHY balance_sheet (quarterly, 2025-10-31) — Preferred Securities Outside Stock Equity: 132287284.00
CHY cash_flow (annual, 2025-10-31) — Preferred Stock Payments: -3.00
CHY balance_sheet (annual, 2025-10-31) — Prepaid Assets: 463877.00
CHY balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 463877.00
CHY income_statement (annual, 2025-10-31) — Pretax Income: 185966018.00
CHY balance_sheet (annual, 2025-10-31) — Receivables: 7606469.00
CHY balance_sheet (quarterly, 2025-10-31) — Receivables: 7606469.00
CHY cash_flow (annual, 2025-10-31) — Repayment Of Debt: -27000000.00
CHY cash_flow (annual, 2025-10-31) — Repurchase Of Capital Stock: -3.00
CHY balance_sheet (annual, 2025-10-31) — Retained Earnings: 37941859.00
CHY balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 37941859.00
CHY income_statement (annual, 2025-10-31) — Selling General And Administration: 589575.00
CHY balance_sheet (annual, 2025-10-31) — Share Issued: 80025019.00
CHY balance_sheet (quarterly, 2025-10-31) — Share Issued: 80025019.00
CHY balance_sheet (annual, 2025-10-31) — Stockholders Equity: 885187638.00
CHY balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 885187638.00
CHY balance_sheet (annual, 2025-10-31) — Tangible Book Value: 885187638.00
CHY balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 885187638.00
CHY income_statement (annual, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
CHY income_statement (annual, 2025-10-31) — Tax Rate For Calcs: 0.21
CHY balance_sheet (annual, 2025-10-31) — Total Assets: 1329082755.00
CHY balance_sheet (quarterly, 2025-10-31) — Total Assets: 1329082755.00
CHY balance_sheet (annual, 2025-10-31) — Total Capitalization: 1186837638.00
CHY balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 1186837638.00
CHY balance_sheet (annual, 2025-10-31) — Total Debt: 301650000.00
CHY balance_sheet (quarterly, 2025-10-31) — Total Debt: 301650000.00
CHY balance_sheet (annual, 2025-10-31) — Total Equity Gross Minority Interest: 885187638.00
CHY balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 885187638.00
CHY balance_sheet (annual, 2025-10-31) — Total Liabilities Net Minority Interest: 443895117.00
CHY balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 443895117.00
CHYM income_statement (annual, 2022-12-31) — +Operating Expense: 1272854000.00
CHYM income_statement (annual, 2022-12-31) — +Total Revenue: 1008838000.00
CHYM balance_sheet (annual, 2022-12-31) — Accounts Payable: 20790000.00
CHYM balance_sheet (annual, 2022-12-31) — Accounts Receivable: 123203000.00
CHYM balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -9297000.00
CHYM balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 353369000.00
CHYM cash_flow (annual, 2022-12-31) — Amortization Of Securities: 2908000.00
CHYM cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 20827000.00
CHYM income_statement (annual, 2022-12-31) — Basic Average Shares: 336399191.00
CHYM income_statement (annual, 2022-12-31) — Basic EPS: -1.41
CHYM cash_flow (annual, 2022-12-31) — Beginning Cash Position: 511055000.00
CHYM cash_flow (annual, 2022-12-31) — Capital Expenditure: -72913000.00
CHYM cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -24185000.00
CHYM balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 100806000.00
CHYM balance_sheet (annual, 2022-12-31) — Capital Stock: 2890122000.00
CHYM balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 203364000.00
CHYM balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 937971000.00
CHYM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1022000.00
CHYM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 150541000.00
CHYM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -434133000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Account Payable: -5960000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -51274000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -42277000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -18444000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Payable: -5960000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -57234000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -11703000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Receivables: -29278000.00
CHYM cash_flow (annual, 2022-12-31) — Change In Working Capital: -158936000.00
CHYM cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -29278000.00
CHYM cash_flow (annual, 2022-12-31) — Changes In Cash: -282570000.00
CHYM balance_sheet (annual, 2022-12-31) — Common Stock: 1000.00
CHYM balance_sheet (annual, 2022-12-31) — Common Stock Equity: -1789078000.00
CHYM cash_flow (annual, 2022-12-31) — Common Stock Payments: -508000.00
CHYM income_statement (annual, 2022-12-31) — Cost Of Revenue: 214686000.00
CHYM balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 68895000.00
CHYM balance_sheet (annual, 2022-12-31) — Current Assets: 1271340000.00
CHYM balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 6269000.00
CHYM balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 6269000.00
CHYM balance_sheet (annual, 2022-12-31) — Current Liabilities: 215515000.00
CHYM cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 7300000.00
CHYM income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 7300000.00
CHYM cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 7300000.00
CHYM income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 7300000.00
CHYM income_statement (annual, 2022-12-31) — Diluted Average Shares: 336399191.00
CHYM income_statement (annual, 2022-12-31) — Diluted EPS: -1.41
CHYM income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -470254000.00
CHYM income_statement (annual, 2022-12-31) — EBIT: -478702000.00
CHYM income_statement (annual, 2022-12-31) — EBITDA: -471402000.00
CHYM cash_flow (annual, 2022-12-31) — End Cash Position: 228485000.00
CHYM cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1022000.00
CHYM cash_flow (annual, 2022-12-31) — Free Cash Flow: -507046000.00
CHYM balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6826000.00
CHYM income_statement (annual, 2022-12-31) — General And Administrative Expense: 169716000.00
CHYM balance_sheet (annual, 2022-12-31) — Gross PPE: 155511000.00
CHYM income_statement (annual, 2022-12-31) — Gross Profit: 794152000.00
CHYM cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 208000.00
CHYM cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
CHYM balance_sheet (annual, 2022-12-31) — Invested Capital: -1789078000.00
CHYM cash_flow (annual, 2022-12-31) — Investing Cash Flow: 150541000.00
CHYM balance_sheet (annual, 2022-12-31) — Leases: 50697000.00
CHYM balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 94537000.00
CHYM balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 94537000.00
CHYM balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 47922000.00
CHYM cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CHYM cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -508000.00
CHYM income_statement (annual, 2022-12-31) — Net Income: -470254000.00
CHYM income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -470254000.00
CHYM income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -470254000.00
CHYM income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -470254000.00
CHYM income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -470254000.00
CHYM cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -470254000.00
CHYM income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -470254000.00
CHYM cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 223454000.00
CHYM balance_sheet (annual, 2022-12-31) — Net PPE: 146214000.00
CHYM cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -48728000.00
CHYM balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1101043000.00
CHYM income_statement (annual, 2022-12-31) — Normalized EBITDA: -471402000.00
CHYM income_statement (annual, 2022-12-31) — Normalized Income: -470254000.00
CHYM cash_flow (annual, 2022-12-31) — Operating Cash Flow: -434133000.00
CHYM income_statement (annual, 2022-12-31) — Operating Income: -478702000.00
CHYM income_statement (annual, 2022-12-31) — Operating Revenue: 1008838000.00
CHYM balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 364421538.00
CHYM balance_sheet (annual, 2022-12-31) — Other Current Assets: 58139000.00
CHYM balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 101805000.00
CHYM balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6826000.00
CHYM income_statement (annual, 2022-12-31) — Other Gand A: 169716000.00
CHYM income_statement (annual, 2022-12-31) — Other Income Expense: 8111000.00
CHYM cash_flow (annual, 2022-12-31) — Other Non Cash Items: 89480000.00
CHYM balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 200000.00
CHYM balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 6659000.00
CHYM income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 8111000.00
CHYM income_statement (annual, 2022-12-31) — Other Operating Expenses: 419180000.00
CHYM balance_sheet (annual, 2022-12-31) — Other Properties: 56892000.00
CHYM balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 734607000.00
CHYM balance_sheet (annual, 2022-12-31) — Payables: 20790000.00
CHYM balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 89685000.00
CHYM balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17756000.00
CHYM balance_sheet (annual, 2022-12-31) — Preferred Stock: 2890121000.00
CHYM balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 2890121000.00
CHYM income_statement (annual, 2022-12-31) — Pretax Income: -470591000.00
CHYM cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1530000.00
CHYM balance_sheet (annual, 2022-12-31) — Properties: 0.00
CHYM cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 46192000.00
CHYM cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CHYM cash_flow (annual, 2022-12-31) — Purchase Of Investment: -426705000.00
CHYM cash_flow (annual, 2022-12-31) — Purchase Of PPE: -48728000.00
CHYM balance_sheet (annual, 2022-12-31) — Receivables: 123203000.00
CHYM income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 214686000.00
CHYM income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7300000.00
CHYM cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -508000.00
CHYM income_statement (annual, 2022-12-31) — Research And Development: 242433000.00
CHYM balance_sheet (annual, 2022-12-31) — Restricted Cash: 152027000.00
CHYM balance_sheet (annual, 2022-12-31) — Retained Earnings: -2135622000.00
CHYM cash_flow (annual, 2022-12-31) — Sale Of Investment: 650159000.00
CHYM income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 434225000.00
CHYM income_statement (annual, 2022-12-31) — Selling General And Administration: 603941000.00
CHYM balance_sheet (annual, 2022-12-31) — Share Issued: 364421538.00
CHYM cash_flow (annual, 2022-12-31) — Stock Based Compensation: 28350000.00
CHYM balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1101043000.00
CHYM balance_sheet (annual, 2022-12-31) — Tangible Book Value: -1789078000.00
CHYM income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (annual, 2022-12-31) — Tax Provision: -337000.00
CHYM income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CHYM balance_sheet (annual, 2022-12-31) — Total Assets: 1417754000.00
CHYM balance_sheet (annual, 2022-12-31) — Total Capitalization: 1101043000.00
CHYM balance_sheet (annual, 2022-12-31) — Total Debt: 100806000.00
CHYM balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1101043000.00
CHYM income_statement (annual, 2022-12-31) — Total Expenses: 1487540000.00
CHYM balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 316711000.00
CHYM balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 146414000.00
CHYM balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 101196000.00
CHYM income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -478702000.00
CHYM balance_sheet (annual, 2022-12-31) — Working Capital: 1055825000.00
CHYM income_statement (annual, 2023-12-31) — +Operating Expense: 1294503000.00
CHYM income_statement (annual, 2023-12-31) — +Total Revenue: 1278455000.00
CHYM balance_sheet (annual, 2023-12-31) — Accounts Payable: 22143000.00
CHYM balance_sheet (annual, 2023-12-31) — Accounts Receivable: 176547000.00
CHYM balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -21657000.00
CHYM balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 384489000.00
CHYM cash_flow (annual, 2023-12-31) — Amortization Of Securities: -14762000.00
CHYM cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CHYM income_statement (annual, 2023-12-31) — Basic Average Shares: 336399191.00
CHYM income_statement (annual, 2023-12-31) — Basic EPS: -0.60
CHYM cash_flow (annual, 2023-12-31) — Beginning Cash Position: 228485000.00
CHYM cash_flow (annual, 2023-12-31) — Capital Expenditure: -27815000.00
CHYM cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -17314000.00
CHYM balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 104894000.00
CHYM balance_sheet (annual, 2023-12-31) — Capital Stock: 2890123000.00
CHYM balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 239745000.00
CHYM balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 800628000.00
CHYM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 842000.00
CHYM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 167012000.00
CHYM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -156594000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Account Payable: 1353000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -11301000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -73835000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -11798000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Payable: 1353000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -9948000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 12198000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Receivables: -53344000.00
CHYM cash_flow (annual, 2023-12-31) — Change In Working Capital: -136727000.00
CHYM cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -53344000.00
CHYM cash_flow (annual, 2023-12-31) — Changes In Cash: 11260000.00
CHYM balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
CHYM balance_sheet (annual, 2023-12-31) — Common Stock Equity: -1953613000.00
CHYM cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CHYM cash_flow (annual, 2023-12-31) — Common Stock Payments: -61000.00
CHYM income_statement (annual, 2023-12-31) — Cost Of Revenue: 219737000.00
CHYM balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 99296000.00
CHYM balance_sheet (annual, 2023-12-31) — Current Assets: 1161839000.00
CHYM balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 11963000.00
CHYM balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 11963000.00
CHYM balance_sheet (annual, 2023-12-31) — Current Liabilities: 288652000.00
CHYM cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 12937000.00
CHYM income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 11621000.00
CHYM cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 12937000.00
CHYM income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 11621000.00
CHYM income_statement (annual, 2023-12-31) — Diluted Average Shares: 336399191.00
CHYM income_statement (annual, 2023-12-31) — Diluted EPS: -0.60
CHYM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -203202000.00
CHYM income_statement (annual, 2023-12-31) — EBIT: -235785000.00
CHYM income_statement (annual, 2023-12-31) — EBITDA: -222848000.00
CHYM cash_flow (annual, 2023-12-31) — End Cash Position: 239745000.00
CHYM cash_flow (annual, 2023-12-31) — Financing Cash Flow: 842000.00
CHYM cash_flow (annual, 2023-12-31) — Free Cash Flow: -184409000.00
CHYM balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 720000.00
CHYM income_statement (annual, 2023-12-31) — General And Administrative Expense: 154945000.00
CHYM balance_sheet (annual, 2023-12-31) — Gross PPE: 179156000.00
CHYM income_statement (annual, 2023-12-31) — Gross Profit: 1058718000.00
CHYM cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 275000.00
CHYM cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 54000.00
CHYM balance_sheet (annual, 2023-12-31) — Invested Capital: -1953613000.00
CHYM cash_flow (annual, 2023-12-31) — Investing Cash Flow: 167012000.00
CHYM cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CHYM balance_sheet (annual, 2023-12-31) — Leases: 58884000.00
CHYM balance_sheet (annual, 2023-12-31) — Loans Receivable: 0.00
CHYM balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 92931000.00
CHYM balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 92931000.00
CHYM balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 67179000.00
CHYM cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CHYM cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -61000.00
CHYM income_statement (annual, 2023-12-31) — Net Income: -203202000.00
CHYM income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -203202000.00
CHYM income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -203202000.00
CHYM income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -203202000.00
CHYM income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -203202000.00
CHYM cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -203202000.00
CHYM income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -203202000.00
CHYM cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 194827000.00
CHYM cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -830000.00
CHYM balance_sheet (annual, 2023-12-31) — Net PPE: 157499000.00
CHYM cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -10501000.00
CHYM balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 936508000.00
CHYM income_statement (annual, 2023-12-31) — Normalized EBITDA: -222848000.00
CHYM income_statement (annual, 2023-12-31) — Normalized Income: -203202000.00
CHYM cash_flow (annual, 2023-12-31) — Operating Cash Flow: -156594000.00
CHYM income_statement (annual, 2023-12-31) — Operating Income: -235785000.00
CHYM income_statement (annual, 2023-12-31) — Operating Revenue: 1278455000.00
CHYM balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 364421538.00
CHYM balance_sheet (annual, 2023-12-31) — Other Current Assets: 45960000.00
CHYM balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 108356000.00
CHYM balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 720000.00
CHYM income_statement (annual, 2023-12-31) — Other Gand A: 154945000.00
CHYM income_statement (annual, 2023-12-31) — Other Income Expense: 32817000.00
CHYM cash_flow (annual, 2023-12-31) — Other Non Cash Items: 76984000.00
CHYM balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 914000.00
CHYM balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 2161000.00
CHYM income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 32817000.00
CHYM income_statement (annual, 2023-12-31) — Other Operating Expenses: 425130000.00
CHYM balance_sheet (annual, 2023-12-31) — Other Properties: 53093000.00
CHYM balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 560883000.00
CHYM balance_sheet (annual, 2023-12-31) — Payables: 22143000.00
CHYM balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 121439000.00
CHYM balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 46894000.00
CHYM balance_sheet (annual, 2023-12-31) — Preferred Stock: 2890121000.00
CHYM balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 2890121000.00
CHYM income_statement (annual, 2023-12-31) — Pretax Income: -202968000.00
CHYM cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1733000.00
CHYM balance_sheet (annual, 2023-12-31) — Properties: 0.00
CHYM cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 67379000.00
CHYM cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CHYM cash_flow (annual, 2023-12-31) — Purchase Of Investment: -610669000.00
CHYM cash_flow (annual, 2023-12-31) — Purchase Of PPE: -10501000.00
CHYM balance_sheet (annual, 2023-12-31) — Receivables: 176547000.00
CHYM income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 218421000.00
CHYM income_statement (annual, 2023-12-31) — Reconciled Depreciation: 12937000.00
CHYM cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -61000.00
CHYM income_statement (annual, 2023-12-31) — Research And Development: 259001000.00
CHYM balance_sheet (annual, 2023-12-31) — Restricted Cash: 138704000.00
CHYM balance_sheet (annual, 2023-12-31) — Retained Earnings: -2338824000.00
CHYM cash_flow (annual, 2023-12-31) — Sale Of Investment: 805496000.00
CHYM income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 443806000.00
CHYM income_statement (annual, 2023-12-31) — Selling General And Administration: 598751000.00
CHYM balance_sheet (annual, 2023-12-31) — Share Issued: 364421538.00
CHYM cash_flow (annual, 2023-12-31) — Stock Based Compensation: 26035000.00
CHYM balance_sheet (annual, 2023-12-31) — Stockholders Equity: 936508000.00
CHYM balance_sheet (annual, 2023-12-31) — Tangible Book Value: -1953613000.00
CHYM income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (annual, 2023-12-31) — Tax Provision: 234000.00
CHYM income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CHYM balance_sheet (annual, 2023-12-31) — Total Assets: 1320252000.00
CHYM balance_sheet (annual, 2023-12-31) — Total Capitalization: 936508000.00
CHYM balance_sheet (annual, 2023-12-31) — Total Debt: 104894000.00
CHYM balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 936508000.00
CHYM income_statement (annual, 2023-12-31) — Total Expenses: 1514240000.00
CHYM balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 383744000.00
CHYM balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 158413000.00
CHYM balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 95092000.00
CHYM income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -235785000.00
CHYM balance_sheet (annual, 2023-12-31) — Working Capital: 873187000.00
CHYM cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
CHYM cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
CHYM cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
CHYM cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
CHYM income_statement (annual, 2024-12-31) — +Operating Expense: 1527957000.00
CHYM income_statement (annual, 2024-12-31) — +Total Revenue: 1673269000.00
CHYM balance_sheet (annual, 2024-12-31) — Accounts Payable: 35846000.00
CHYM balance_sheet (annual, 2024-12-31) — Accounts Receivable: 216161000.00
CHYM balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -45512000.00
CHYM balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 433363000.00
CHYM cash_flow (annual, 2024-12-31) — Amortization Of Securities: -12531000.00
CHYM cash_flow (quarterly, 2024-12-31) — Amortization Of Securities: -2025000.00
CHYM cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1901000.00
CHYM cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 592000.00
CHYM income_statement (annual, 2024-12-31) — Basic Average Shares: 364421538.00
CHYM income_statement (annual, 2024-12-31) — Basic EPS: -0.07
CHYM cash_flow (annual, 2024-12-31) — Beginning Cash Position: 239745000.00
CHYM cash_flow (annual, 2024-12-31) — Capital Expenditure: -14469000.00
CHYM cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -9657000.00
CHYM balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 96336000.00
CHYM balance_sheet (annual, 2024-12-31) — Capital Stock: 2890123000.00
CHYM balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 337697000.00
CHYM balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 706586000.00
CHYM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 456000.00
CHYM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 45659000.00
CHYM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 64140000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Account Payable: 13703000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 33552000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -44044000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -43019000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Payable: 13703000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 47255000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -24115000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Receivables: -40307000.00
CHYM cash_flow (annual, 2024-12-31) — Change In Working Capital: -104230000.00
CHYM cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -40307000.00
CHYM cash_flow (annual, 2024-12-31) — Changes In Cash: 110255000.00
CHYM balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
CHYM balance_sheet (annual, 2024-12-31) — Common Stock Equity: -1930600000.00
CHYM cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CHYM cash_flow (annual, 2024-12-31) — Common Stock Payments: -950000.00
CHYM income_statement (annual, 2024-12-31) — Cost Of Revenue: 207511000.00
CHYM balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 108245000.00
CHYM balance_sheet (annual, 2024-12-31) — Current Assets: 1287036000.00
CHYM balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 15746000.00
CHYM balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 15746000.00
CHYM balance_sheet (annual, 2024-12-31) — Current Liabilities: 374817000.00
CHYM cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 25370000.00
CHYM income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 14850000.00
CHYM cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 25370000.00
CHYM income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 14850000.00
CHYM income_statement (annual, 2024-12-31) — Diluted Average Shares: 364421538.00
CHYM income_statement (annual, 2024-12-31) — Diluted EPS: -0.07
CHYM income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -25344000.00
CHYM income_statement (annual, 2024-12-31) — EBIT: -62199000.00
CHYM income_statement (annual, 2024-12-31) — EBITDA: -36829000.00
CHYM cash_flow (annual, 2024-12-31) — End Cash Position: 350000000.00
CHYM cash_flow (annual, 2024-12-31) — Financing Cash Flow: 456000.00
CHYM cash_flow (annual, 2024-12-31) — Free Cash Flow: 49671000.00
CHYM balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 203000.00
CHYM income_statement (annual, 2024-12-31) — General And Administrative Expense: 177229000.00
CHYM balance_sheet (annual, 2024-12-31) — Gross PPE: 187544000.00
CHYM income_statement (annual, 2024-12-31) — Gross Profit: 1465758000.00
CHYM cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 2178000.00
CHYM cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 467000.00
CHYM balance_sheet (annual, 2024-12-31) — Invested Capital: -1930600000.00
CHYM cash_flow (annual, 2024-12-31) — Investing Cash Flow: 45659000.00
CHYM cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CHYM balance_sheet (annual, 2024-12-31) — Leases: 61736000.00
CHYM balance_sheet (annual, 2024-12-31) — Loans Receivable: 99799000.00
CHYM balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 80590000.00
CHYM balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 80590000.00
CHYM balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 76476000.00
CHYM cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -13336000.00
CHYM cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -2300000.00
CHYM cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -950000.00
CHYM income_statement (annual, 2024-12-31) — Net Income: -25344000.00
CHYM income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -25344000.00
CHYM income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -25344000.00
CHYM income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -25344000.00
CHYM income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -25344000.00
CHYM cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -25344000.00
CHYM income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -25344000.00
CHYM cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 203911000.00
CHYM cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -130447000.00
CHYM balance_sheet (annual, 2024-12-31) — Net PPE: 142032000.00
CHYM cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4812000.00
CHYM balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 959521000.00
CHYM income_statement (annual, 2024-12-31) — Normalized EBITDA: -36829000.00
CHYM income_statement (annual, 2024-12-31) — Normalized Income: -25344000.00
CHYM cash_flow (annual, 2024-12-31) — Operating Cash Flow: 64140000.00
CHYM income_statement (annual, 2024-12-31) — Operating Income: -62199000.00
CHYM income_statement (annual, 2024-12-31) — Operating Revenue: 1673269000.00
CHYM balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 364421538.00
CHYM balance_sheet (annual, 2024-12-31) — Other Current Assets: 70464000.00
CHYM balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 161636000.00
CHYM balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 203000.00